Download Files:
Products Details
Product Description
– Zerlasiran sodium is an apolipoprotein A (ApoA) synthesis reducer[1].
Web ID
– HY-147425A
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C443H556F12N144Na38O277P40S10
References
– [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
Molecular Weight
– 14991.12
SMILES
– [Zerlasiran (sodium)]
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in H2O
Target
– Small Interfering RNA (siRNA)
Pathway
– Epigenetics
Product type
– Oligonucleotides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
